About this trial
1. Establish a multimodality imaging database for PVD, improve the one-stop screening process for early PVD based on artificial intelligence, build a full-cycle control information platform, and promote the construction and standardization of a multidisciplinary co-morbidity and co-management diagnosis and treatment model. 2. Based on non-invasive, zero-contrast ocular OCTA combined with one-stop CTA imaging of the heart and brain, construct an integrated "eye-heart-brain" early warning model for PVD, and explore a potential non-invasive and convenient early warning system for PVD. 3. Based on the multi-omics, investigate EVs-mediated intercellular communication network, elucidate the roles and regulatory mechanisms of EVs in the development of PVD, search for potential targets for intervention, and construct an artificial intelligence-based "pan-vascular score" risk assessment system based on the combination of multi-modality imaging and multi-omics biomarkers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with coronary artery disease (≥50% stenosis in any coronary artery on coronary angiography)
Age ≥18 years old
Proposed OCT-IVUS integrated imaging system
able to provide written informed consent prior to the start of any procedures related to the study.
Disqualifiers
severely tortuous/calcified coronary arteries with anticipated difficulty in completing the OCT-IVUS integrated imaging system
uncontrolled congestive heart failure or acute left heart failure;plan
claustrophobia;
left main stem occlusion;
Trial population
Patients with polyvascular disease in the 2nd Affiliated Hospital of Harbin Medical University
Trial design
Cohort
Prospective
Treatments tested in this trial
Magnetic Resonance Angiography, Ocular OCTA, CT Angiography
Diagnostic testMagnetic Resonance Angiography of intracranial artery, carotid artery, renal artery and lower extremity artery, CT angiography of coronary artery or intracranial artery
Treatment groups
Trial outcomes
Primary outcomes
Task1: MACE
All cause death, stroke, myocardial reinfarction, unplanned revascularization, lower extremity artery disease
Task2: Plaque characteristics
Plaque morphology on OCT
Sponsors and contacts
Click on the lead sponsor to view all of their trials.